MANGALAM GLOBAL ENTERPRISE
Back to Balance Sheet
|
MANGALAM GLOBAL ENTERPRISE Last 5 Year Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Current Liabilities | - | - | - | - | - |
What is the latest Current Liabilities ratio of MANGALAM GLOBAL ENTERPRISE ?
| Year | Current Liabilities |
|---|---|
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
| Mar2021 | - |
How is Current Liabilities of MANGALAM GLOBAL ENTERPRISE Trending?
| Years | Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | - | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | 0 | |
| Mar2021 | - | - | |
Compare Current Liabilities of peers of MANGALAM GLOBAL ENTERPRISE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANGALAM GLOBAL ENTERPRISE | ₹474.6 Cr | -0.7% | -18.5% | 15.7% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹12,850.9 Cr | -5.4% | -4.2% | -31% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹5,500.4 Cr | 7.1% | 1.1% | 15.6% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,906.4 Cr | -0.2% | -7.4% | -23.1% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,219.6 Cr | -4.1% | -3.1% | -27.1% | Stock Analytics | |
| INDO US BIOTECH | ₹248.4 Cr | -0.8% | -0.3% | -48.8% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANGALAM GLOBAL ENTERPRISE | -0.7% |
-18.5% |
15.7% |
| SENSEX | 1.7% |
3.6% |
6.9% |
You may also like the below Video Courses